Education
About Us
Working with TipRanks
Follow Us
ScandiDos AB (SE:SDOS)
:SDOS
SDOS Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.16 - kr1.83
Previous CloseN/A
Volume16.76K
Average Volume (3M)25.46K
Market Cap
kr75.25M
Enterprise Valuekr74.46M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)231.6
Beta0.07
Next Earnings
Sep 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding57,011,086
10 Day Avg. Volume33,919
30 Day Avg. Volume25,462
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SDOS FAQ
What was ScandiDos AB’s price range in the past 12 months?
ScandiDos AB lowest stock price was kr1.16 and its highest was kr1.83 in the past 12 months.
What is ScandiDos AB’s market cap?
ScandiDos AB’s market cap is kr75.25M.
When is ScandiDos AB’s upcoming earnings report date?
ScandiDos AB’s upcoming earnings report date is Sep 18, 2025 which is in 37 days.
How were ScandiDos AB’s earnings last quarter?
Currently, no data Available
Is ScandiDos AB overvalued?
According to Wall Street analysts ScandiDos AB’s price is currently Overvalued.
Does ScandiDos AB pay dividends?
ScandiDos AB does not currently pay dividends.
What is ScandiDos AB’s EPS estimate?
ScandiDos AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ScandiDos AB have?
ScandiDos AB has 57,011,086 shares outstanding.
What happened to ScandiDos AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ScandiDos AB?
Currently, no hedge funds are holding shares in SE:SDOS
Company Description
ScandiDos AB
ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; and Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation. The company was founded in 2005 and is headquartered in Uppsala, Sweden.
ScandiDos AB (SDOS) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
C-Rad AB Class B
―
Stayble Therapeutics AB
―
Vicore Pharma Holding AB
―
Vivesto AB
―
Prostatype Genomics AB
―